Rapid attainment of reliable anti-Xa levels with combined intravenous and subcutaneous enoxaparin in acute coronary syndromes: The PEPCI PRE study.

被引：0
|
作者：
Martin, JL
Fry, ET
Sanderink, GJ
Atherley, TH
Martin, TS
Mayhew, KE
机构：
[1] Bryn Mawr Hosp, Bryn Mawr, PA USA
[2] St Vincents Hosp, Indianapolis, IN USA
[3] Aventis Pharmaceut, Paris, France
[4] Israel Med Ctr, Newark, NJ USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 94卷 / 6A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：85E / 85E
页数：1
相关论文
共 6 条
  • [1] Rapid attainment of reliable anti-xa levels with combined intravenous and subcutaneous enoxaparin in acute coronary syndromes; the PEPCI PRE study
    Martin, J
    Fry, E
    Sanderink, JG
    Atherley, TH
    Pensyl, C
    Mayhew, K
    Buszman, P
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 87 - 87
  • [2] Anti-Xa activity relates to outcome in acute coronary syndromes treated with Enoxaparin
    Montalescot, G
    Collet, JP
    Payot, L
    Choussat, R
    Beygui, F
    Gallois, V
    Metzger, JP
    Thomas, D
    [J]. CIRCULATION, 2003, 108 (17) : 501 - 501
  • [3] Anti-Xa monitoring of enoxaparin for acute coronary syndromes in patients with renal disease
    Ma, JM
    Jackevicius, CA
    Yeo, E
    [J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (10) : 1576 - 1581
  • [4] Pharmacokinetic study of Enoxaparin in patients undergoing coronary intervention after treatment with subcutaneous enoxaparin in acute coronary syndromes: The PEPCI study
    Martin, JL
    Fry, ET
    Sanderink, G
    Atherley, T
    Ozoux, ML
    Guimart, C
    Chevalier, P
    Pensyl, C
    Serano, A
    Bigonzi, F
    Sydney, C
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (5A): : 10G - 11G
  • [5] Pharmacokinetic study of enoxaparin in patients undergoing coronary intervention after treatment with subcutaneous enoxaparin in acute coronary syndromes. The PEPCI study
    Martin, JL
    Fry, ETA
    Serano, A
    Atherley, TH
    Ozoux, ML
    Guimart, C
    Chevalier, P
    Bigonzi, F
    Pensyl, C
    Sanderink, GJ
    [J]. EUROPEAN HEART JOURNAL, 2001, 22 : 14 - 14
  • [6] A novel enoxaparin regime for ST-elevation myocardial infarction patients undergoing primary purcutaneous coronary intervention: Intravenous but not subcutaneous enoxaparin achieves adequate anti-Xa levels
    Welsh, RC
    Gordon, P
    Westerhout, CM
    Buller, CE
    O'Neill, BJ
    Cheung, PK
    Armstrong, PW
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 228A - 228A
1